Charles M. Balch: specializing surgeons is going to be a trend

Posted On 2014-08-19 14:15:02

Dr. Charles M. Balch, M.D., FACS, Professor of Surgery, University of Texas Southwestern Medical Center, prior Deputy Director for Clinical Trials and Outcomes Research at Johns Hopkins Institute and Executive Vice President and Chief Executive Officer of American Society of Clinical Oncology (ASCO), enjoys a worldwide reputation for his distinguished career as a clinical and academic oncologist for the past 35 years and a leading authority in both melanoma and breast cancer. In 2012 Chinese Society of Clinical Oncology (CSCO), Chinese Clinical Oncology (CCO) had the honor to interview Dr. Charles regarding the topic of specializing surgeons, achievements in melanoma agent development and challenge ahead of him in his medical research. At the end of the interview, as an authority in medical research publication, Dr. Balch also encouraged Chinese researchers to be strong in scientific English since medical research in China is significant to medical research in the whole world.


Dr. Charles M. Balch